FdaApplication
ANDA 206383
Identifiers
- fda_app_no: ANDA206383
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2016-09-29 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ARIPIPRAZOLE | ARIPIPRAZOLE | 2MG | TABLET;ORAL |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 5MG | TABLET;ORAL |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 10MG | TABLET;ORAL |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 20MG | TABLET;ORAL |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 30MG | TABLET;ORAL |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 15MG | TABLET;ORAL |
6 products